This page includes the latest FDA filings for Incyte Corp. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| USA | NASDAQ | INCY | DUNS 556967347 |
Device Company | Device | Date |
|---|---|---|
| Incyte Corporation | Prescription Medication | 2024-04-18 |
| Incyte Corporation | Prescription Medication | 2023-11-22 |
| Incyte Corporation | Prescription Medication | 2023-10-04 |
| Incyte Corporation | Prescription Medication | 2023-06-15 |
| Incyte Corporation | Prescription Medication | 2023-04-20 |
| Incyte Corporation | Prescription Medication | 2023-04-04 |
| Incyte Corporation | Prescription Medication | 2023-02-09 |
| Incyte Corporation | Prescription Medication | 2023-01-18 |
| Incyte Corporation | Prescription Medication | 2023-01-07 |
| Incyte Corporation | Prescription Medication | 2023-01-07 |
| Incyte Corporation | Prescription Medication | 2022-12-23 |
| Incyte Corporation | Prescription Medication | 2022-10-05 |
| Incyte Corporation | Prescription Medication | 2022-09-10 |
| Incyte Corporation | Prescription Medication | 2022-08-03 |
| Incyte Corporation | Prescription Medication | 2022-04-30 |
| Incyte Corporation | Prescription Medication | 2022-04-26 |
| Incyte Corporation | Prescription Medication | 2022-01-15 |
| Incyte Corporation | Prescription Medication | 2021-10-02 |
INCYTE CORP | 2021-09-28 20:51:54 | |
| Incyte Corporation | Prescription Medication | 2021-09-25 |
| Incyte Corporation | OPZELURA | 2021-09-21 |
| Incyte Corporation | Prescription Medication | 2021-06-17 |
| Incyte Corporation | Prescription Medication | 2021-03-07 |
| Incyte Corporation | Prescription Medication | 2020-04-23 |
| Incyte Corporation | PEMAZYRE | 2020-04-17 |
| Incyte Corporation | PEMAZYRE | 2020-04-17 |
| Incyte Corporation | PEMAZYRE | 2020-04-17 |
| Incyte Corporation | Prescription Medication | 2020-02-27 |
| Incyte Corporation | Prescription Medication | 2020-01-29 |
| Incyte Corporation | Prescription Medication | 2020-01-16 |
| Incyte Corporation | Prescription Medication | 2019-06-05 |
| Incyte Corporation | JAKAFI | 2011-11-16 |
| Incyte Corporation | JAKAFI | 2011-11-16 |
| Incyte Corporation | JAKAFI | 2011-11-16 |
| Incyte Corporation | JAKAFI | 2011-11-16 |
| Incyte Corporation | JAKAFI | 2011-11-16 |
INCYTE CORP | 0000-00-00 00:00:00 | |
INCYTE CORP | 0000-00-00 00:00:00 |
| NCAGE Code | 1F8A9 | INCYTE CORPORATION |
| CAGE Code | 1F8A9 | INCYTE CORPORATION |
| S.A.M. Registration | 1F8A9 [556967347] | INCYTE CORPORATION |
| SEC | 0000879169 | INCYTE CORP of DELAWARE |
| Import ID | Shipment | Cargo Description | Quantity |
|---|---|---|---|
| 2018051119132 | Anvers,Belgium -> Philadelphia, Pennsylvania | AMINOXADIAZOLOXIM H.S. 2934.99 UN 3222, SELF-REACTIVE SOLID TYPE B (AMINOXADIAZOLE), CLASS 4.1, PACKING GROUP N/A, NET QUANTITY 0.00148 KG TEMPERATURE SETTING AT PLUS 20 | 1 PCS |
| 2018050429977 | Anvers,Belgium -> Philadelphia, Pennsylvania | AMINOXADIAZOLOXIM H.S. 2934.99 UN 3222, SELF-REACTIVE SOLID TYPE B (AMINOXADIAZOLE), CLASS 4.1, PACKING GROUP N/A, NET QUANTITY 0.00148 KG TEMPERATURE SETTING AT PLUS 20 | 1 PCS |
| 2018042827416 | Anvers,Belgium -> Philadelphia, Pennsylvania | AMINOXADIAZOLOXIM H.S. 2934.99 UN 3222, SELF-REACTIVE SOLID TYPE B (AMINOXADIAZOLE), CLASS 4.1, PACKING GROUP N/A, NET QUANTITY 0.00148 KG TEMPERATURE SETTING AT PLUS 20 | 1 PCS |